Bpifrance

// WOWL ASSESSMENT

Bpifrance is the French state investment bank deploying sovereign capital into domestic champions — a strategic national instrument wrapped in VC packaging. The portfolio reads like a who's-who of French scale-up winners from the 2015-2020 era, but the thesis is national interest first, returns second. Nine companies at $19B combined valuation with zero exits tells you everything: this is patient capital underwriting French tech sovereignty, not venture capital hunting rapid multiples. The 11% hit rate masks the real mandate — building Paris as a European tech hub regardless of market conditions.

The portfolio contains genuine European leaders: Contentsquare owns digital experience analytics, Exotec builds warehouse robotics at scale, PayFit dominates French HR software. But nearly every company is marked BLOATED or ARMED in the WOWLS matrix — they raised at peak 2021 valuations and now face grinding path to justify the numbers. Ynsect's $1B insect protein bet looks increasingly like a ZOMBIECORN as the category fails to scale. Zero exits across nine unicorns after years of holding proves the patient capital thesis — or reveals the exit problem when national pride prevents realistic pricing.

// THREAT LEVEL: TOO BIG TO FAIL

VERDICT: State capital masquerading as venture capital — the mandate is French tech sovereignty, the portfolio is the collateral damage of that mission.